NYSE:WSTLife Sciences
Is West Pharmaceutical Services (WST) Pricey As GLP 1 Demand Lifts Expectations?
Investor interest in West Pharmaceutical Services (WST) has been rising as demand for GLP-1 therapies expands, spotlighting the company’s injectable drug containment and delivery systems while also drawing attention to capacity and pricing concerns.
See our latest analysis for West Pharmaceutical Services.
West Pharmaceutical Services’ share price has gained 36.18% over the past 90 days and 21.70% year to date, while the 1 year total shareholder return of 51.56% points to strong momentum...

